Gynecomastia attributable to human chorionic gonadotropin-secreting giant cell carcinoma of lung

Subhashini Yaturu, Elba Harrara, Charan Nopajaroonsri, Rakesh Singal, Sarjit Gill

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Objective: To describe a patient with human chorionic gonadotropin (hCG)-secreting giant cell carcinoma of the lung manifesting as painful gynecomastia, which resolved after surgical treatment. Methods: We present the clinical, radiologic, and clinical course of our patient, who presented with painful gynecomastia. Results: A 51-year-old man presented with a lung mass and rapidly progressing bilateral painful gynecomastia. Hormonal evaluation revealed high levels of hCG β subunit, estradiol, and total and free testosterone and suppressed levels of luteinizing hormone and follicle-stimulating hormone. The patient underwent resection of the right upper and middle lobes of the lung. After the surgical procedure, the levels of hCG and estradiol rapidly decreased, and the gynecomastia resolved completely within 3 months. Fluctuation in the levels of serum hCG paralleled the clinical course of the lung tumor. Conclusion: Although gynecomastia is a common disorder, hormonal work-up including hCG β subunit should be done in an adult male patient presenting with rapidly progressing or recent onset of painful gynecomastia. Lung cancer should be considered in the differential diagnosis of gynecomastia attributable to ectopic production of hCG β subunit.

Original languageEnglish
Pages (from-to)233-235
Number of pages3
JournalEndocrine Practice
Volume9
Issue number3
StatePublished - May 1 2003
Externally publishedYes

Fingerprint

Giant Cell Carcinoma
Gynecomastia
Chorionic Gonadotropin
Lung
Estradiol
Follicle Stimulating Hormone
Luteinizing Hormone
Testosterone
Lung Neoplasms
Differential Diagnosis

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Gynecomastia attributable to human chorionic gonadotropin-secreting giant cell carcinoma of lung. / Yaturu, Subhashini; Harrara, Elba; Nopajaroonsri, Charan; Singal, Rakesh; Gill, Sarjit.

In: Endocrine Practice, Vol. 9, No. 3, 01.05.2003, p. 233-235.

Research output: Contribution to journalArticle

Yaturu, S, Harrara, E, Nopajaroonsri, C, Singal, R & Gill, S 2003, 'Gynecomastia attributable to human chorionic gonadotropin-secreting giant cell carcinoma of lung', Endocrine Practice, vol. 9, no. 3, pp. 233-235.
Yaturu, Subhashini ; Harrara, Elba ; Nopajaroonsri, Charan ; Singal, Rakesh ; Gill, Sarjit. / Gynecomastia attributable to human chorionic gonadotropin-secreting giant cell carcinoma of lung. In: Endocrine Practice. 2003 ; Vol. 9, No. 3. pp. 233-235.
@article{5401fe36f7554e3c84d079026e81904c,
title = "Gynecomastia attributable to human chorionic gonadotropin-secreting giant cell carcinoma of lung",
abstract = "Objective: To describe a patient with human chorionic gonadotropin (hCG)-secreting giant cell carcinoma of the lung manifesting as painful gynecomastia, which resolved after surgical treatment. Methods: We present the clinical, radiologic, and clinical course of our patient, who presented with painful gynecomastia. Results: A 51-year-old man presented with a lung mass and rapidly progressing bilateral painful gynecomastia. Hormonal evaluation revealed high levels of hCG β subunit, estradiol, and total and free testosterone and suppressed levels of luteinizing hormone and follicle-stimulating hormone. The patient underwent resection of the right upper and middle lobes of the lung. After the surgical procedure, the levels of hCG and estradiol rapidly decreased, and the gynecomastia resolved completely within 3 months. Fluctuation in the levels of serum hCG paralleled the clinical course of the lung tumor. Conclusion: Although gynecomastia is a common disorder, hormonal work-up including hCG β subunit should be done in an adult male patient presenting with rapidly progressing or recent onset of painful gynecomastia. Lung cancer should be considered in the differential diagnosis of gynecomastia attributable to ectopic production of hCG β subunit.",
author = "Subhashini Yaturu and Elba Harrara and Charan Nopajaroonsri and Rakesh Singal and Sarjit Gill",
year = "2003",
month = "5",
day = "1",
language = "English",
volume = "9",
pages = "233--235",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "3",

}

TY - JOUR

T1 - Gynecomastia attributable to human chorionic gonadotropin-secreting giant cell carcinoma of lung

AU - Yaturu, Subhashini

AU - Harrara, Elba

AU - Nopajaroonsri, Charan

AU - Singal, Rakesh

AU - Gill, Sarjit

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Objective: To describe a patient with human chorionic gonadotropin (hCG)-secreting giant cell carcinoma of the lung manifesting as painful gynecomastia, which resolved after surgical treatment. Methods: We present the clinical, radiologic, and clinical course of our patient, who presented with painful gynecomastia. Results: A 51-year-old man presented with a lung mass and rapidly progressing bilateral painful gynecomastia. Hormonal evaluation revealed high levels of hCG β subunit, estradiol, and total and free testosterone and suppressed levels of luteinizing hormone and follicle-stimulating hormone. The patient underwent resection of the right upper and middle lobes of the lung. After the surgical procedure, the levels of hCG and estradiol rapidly decreased, and the gynecomastia resolved completely within 3 months. Fluctuation in the levels of serum hCG paralleled the clinical course of the lung tumor. Conclusion: Although gynecomastia is a common disorder, hormonal work-up including hCG β subunit should be done in an adult male patient presenting with rapidly progressing or recent onset of painful gynecomastia. Lung cancer should be considered in the differential diagnosis of gynecomastia attributable to ectopic production of hCG β subunit.

AB - Objective: To describe a patient with human chorionic gonadotropin (hCG)-secreting giant cell carcinoma of the lung manifesting as painful gynecomastia, which resolved after surgical treatment. Methods: We present the clinical, radiologic, and clinical course of our patient, who presented with painful gynecomastia. Results: A 51-year-old man presented with a lung mass and rapidly progressing bilateral painful gynecomastia. Hormonal evaluation revealed high levels of hCG β subunit, estradiol, and total and free testosterone and suppressed levels of luteinizing hormone and follicle-stimulating hormone. The patient underwent resection of the right upper and middle lobes of the lung. After the surgical procedure, the levels of hCG and estradiol rapidly decreased, and the gynecomastia resolved completely within 3 months. Fluctuation in the levels of serum hCG paralleled the clinical course of the lung tumor. Conclusion: Although gynecomastia is a common disorder, hormonal work-up including hCG β subunit should be done in an adult male patient presenting with rapidly progressing or recent onset of painful gynecomastia. Lung cancer should be considered in the differential diagnosis of gynecomastia attributable to ectopic production of hCG β subunit.

UR - http://www.scopus.com/inward/record.url?scp=2342594636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342594636&partnerID=8YFLogxK

M3 - Article

C2 - 12917067

AN - SCOPUS:2342594636

VL - 9

SP - 233

EP - 235

JO - Endocrine Practice

JF - Endocrine Practice

SN - 1530-891X

IS - 3

ER -